Hershey Trust Company’s Audentes Therapeutics, Inc BOLD Stock Holding History

Hershey Trust Company’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-11,009	Closed	-$659K	–	34
2019 Q4	$659K	Buy	+11,009	New	+$413K	0.01%	11
2019 Q2	–	Sell	-7,980	Closed	-$311K	–	23
2019 Q1	$311K	Buy	+7,980	New	+$229K	﹤0.01%	13

Hershey Trust Company's BOLD Position: Q1 2020 in Review

Hershey Trust Company sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 11,009 shares — an estimated $659K sold.

Hershey Trust Company first reported a position in BOLD in Q1 2019 and held it in 2 quarters. The position peaked at $659K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Hershey Trust Company reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Hershey Trust Company sold 11,009 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $659K.
Hershey Trust Company first reported a position in Audentes Therapeutics, Inc in Q1 2019 and held it in 2 quarters.
Hershey Trust Company's Audentes Therapeutics, Inc position peaked at $659K in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Hershey Trust Company's 13F filing for Q1 2020, filed 20 Apr 2020.